Bullisch
$19.80
Szenariopreis
$19.170
-0.140 (-0.73%)Zum Schluss
Sabra Health Care REIT Inc operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company's primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector. The Company invests primarily in the United States nursing home industry, including skilled nursing and transitional care facilities, the United States and Canadian senior housing industry, which includes independent living, assisted living, memory care and continuing care retirement communities, select behavioral health and addiction treatment centers, and acute care and other hospitals. Its skilled nursing facilities provide services that include daily nursing, therapeutic rehabilitation, social services, activities, housekeeping, nutrition, medication management and administrative services for individuals.
Sabra Health Care REIT Inc is currently a hold. The stock is trading at $18.96, which is below the analyst price targets of $21 to $25, suggesting potential upside. However, the RSI is at 31.401, indicating it is oversold, and the recent net loss of $0.10 per share in Q2 2026 raises concerns about profitability. The forward P/E ratio of 32.1543 suggests the stock may be overvalued relative to its earnings potential, which is a risk for long-term investors.
Huntington
$23
2026-09-10
Huntington
2026-09-10
Kursziel
$23
Mizuho
$21
2026-08-31
Mizuho
2026-08-31
Kursziel
$21
Barclays
$23
2026-08-31
Barclays
2026-08-31
Kursziel
$23
Raymond James
—
2026-08-06
Raymond James
2026-08-06
Kursziel
—
Deutsche Bank
$25
2026-07-22
Deutsche Bank
2026-07-22
Kursziel
$25
Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

Sabra Health Care REIT Q2 2026 Earnings Call Highlights

Sabra Health Care Declares Quarterly Dividend of $0.30

Sabra Health Care Reports Q2 2026 Earnings Results

US Reinstates Tariffs Impacting Market Dynamics

Sabra Releases 2025 Sustainability Report Highlighting Key Innovations
Sabra Health Care REIT Inc operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company's primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector. The Company invests primarily in the United States nursing home industry, including skilled nursing and transitional care facilities, the United States and Canadian senior housing industry, which includes independent living, assisted living, memory care and continuing care retirement communities, select behavioral health and addiction treatment centers, and acute care and other hospitals. Its skilled nursing facilities provide services that include daily nursing, therapeutic rehabilitation, social services, activities, housekeeping, nutrition, medication management and administrative services for individuals. It operates in the Real Estate sector (REAL ESTATE INVESTMENT TRUSTS industry).
Sabra Health Care REIT Inc is currently a hold. The stock is trading at $18.96, which is below the analyst price targets of $21 to $25, suggesting potential upside. However, the RSI is at 31.401, indicating it is oversold, and the recent net loss of $0.10 per share in Q2 2026 raises concerns about profitability. The forward P/E ratio of 32.1543 suggests the stock may be overvalued relative to its earnings potential, which is a risk for long-term investors.
12 analysts cover SBRA: 4 rate it Buy, 7 Hold and 1 Sell. The average price target is 20.83.
Noch keine Beiträge
Registriere dich oder melde dich an, um mitzudiskutierenDiese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.